Recently, results from colon cancer cells and xenograft tumor models have demonstrated that RAS protein activator-like 1 inhibits colon cancer cell proliferation by regulating LXRα/SREBP1c-mediated SCD1 activity (68). Here, SREBF1 is linked to colonic neoplasm.